Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Bangladesh
  4. Dhaka Stock Exchange
  5. Beximco Pharmaceuticals Limited
  6. Company
    BXPHARMA   BD0453BXPH04

BEXIMCO PHARMACEUTICALS LIMITED

(BXPHARMA)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Beximco Pharmaceuticals Limited (BPL) is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The Company also provides contract manufacturing services. The Company produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal. Its product categories also include anti-infectives, musculoskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. The Company's products include Acifix, Femzole, Q-Rash, Tamona, Taverin, Tobasol, IcyKool Cream, Intracef, Gastalfet, Iprasol, Calorate, Gentosep and others. BPL's products are sold in domestic and international markets.
Sales per Business
20192020Delta
Pharmaceutical Formulations and Active Pharmaceutical Ingredients22 816.60100%25 611.90100% +12.25%
BDT in Million
Sales per region
20192020Delta
Bangladesh22 816.60100%25 611.90100% +12.25%
BDT in Million
Managers
Name Title Age Since
Nazmul Hassan Chief Executive Officer, Director & MD 57 2013
Ali Nawaz Chief Financial Officer 58 2003
Selina Akter Executive Director-Medical Affairs Department - -
Rabbur Reza Chief Operating Officer - 2005
Mamtaz Uddin Ahmed Independent Non-Executive Director - 2020
Mohammad Ibraheem Hosein Khan, Dr. Independent Director 61 2021
Mohammad Asad Ullah Secretary & Executive Director-Management Team - 2013
Mohamed Zakaria Seraj Chowdhury Director-International Marketing - 2011
Rizvi Ul Kabir Marketing Director - 2017
Afsaruddin Ahmed Commercial Director - 2003
Members of the board
Name Title Age Since
Ahmed Sohail Fasihur Rahman Chairman - 2011
Nazmul Hassan Chief Executive Officer, Director & MD 57 2013
Ahmed Salman Fasiur Rahman Vice Chairman - 2010
Iqbal Ahmed Director - 1985
Osman Kaiser Chowdhury Director - 1991
Abu Bakar Siddiqur Rahman Director - 1993
Mamtaz Uddin Ahmed Independent Non-Executive Director - 2020
Quamrun Naher Ahmed Non-Executive Director 61 2020
Reem H. Shamsuddoha Non-Executive Director 33 2020
Mohammad Ibraheem Hosein Khan, Dr. Independent Director 61 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 446,112,089 420,619,971 94.3% 0 0.0% 94.3%
Shareholders
NameEquities%
Norges Bank Investment Management 14,524,404 3.26%
East Capital Financial Services AB 2,573,410 0.58%
Legal & General Investment Management Ltd. 1,663,079 0.37%
Franklin Templeton Investments (ME) Ltd. 1,420,358 0.32%
BlackRock Fund Advisors 1,145,473 0.26%
Tundra Fonder AB 1,000,000 0.22%
Russell Investments Ltd. 998,671 0.22%
Parametric Portfolio Associates LLC 207,136 0.046%
Exchange Traded Concepts LLC 132,921 0.030%
Banor Capital Ltd. 83,883 0.019%
Company contact information
Beximco Pharmaceuticals Ltd.
17 Dhanmondi R/A
House No. 17
Road No. 2
Dhaka 1205

Phone : +880.2.58611891
Fax : +880.2.58613470
Web : http://www.beximco-pharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Beximco Pharmaceuticals Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
BEXIMCO PHARMACEUTICALS LIMITED1.82%1 031
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642
NOVO NORDISK A/S-15.89%213 450
MERCK & CO., INC.3.26%199 903
NOVARTIS AG-2.64%189 740
ASTRAZENECA PLC-2.27%177 586
BRISTOL-MYERS SQUIBB COMPANY-0.18%138 151
SANOFI3.79%130 219
AMGEN INC.-1.08%125 349
GLAXOSMITHKLINE PLC1.57%110 966
BAYER AG9.68%57 141
CHUGAI PHARMACEUTICAL CO., LTD-1.02%53 161
TAKEDA PHARMACEUTICAL COMPANY LIMITED5.45%45 060
DAIICHI SANKYO CO., LTD.-11.11%43 582
JIANGSU HENGRUI MEDICINE CO., LTD.-17.00%42 423
ASTELLAS PHARMA INC.0.72%30 528
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-18.88%19 826